Loading [MathJax]/jax/output/SVG/jax.js
Research article Special Issues

Phadiatop Seropositivity in Schizophrenia Patients and Controls: A Preliminary Study

  • There is a dearth of information on the association of atopy with schizophrenia. The few available studies used population-based registers to classify the atopy status of the patients but this strategy is not reliable. This study measured seropositivity with a multiallergen screen of allergen specific IgE antibodies in schizophrenia patients versus healthy controls. A subset of 66 schizophrenia patients and 34 healthy controls were randomly selected from a large comparative study of schizophrenia patients and controls. The Phadiatop multi-allergen screen was performed on sera from all the participants to assess their atopic status. Logistic regression was used to calculate the odds ratio for the association of schizophrenia with Phadiatop seropositivity as a measure of atopy. The prevalence of Phadiatop seropositivity was significantly lower (χ2 4.59, p = 0.032) and there was a reduced odds ratio for atopy in schizophrenia patients relative to controls (OR 0.40; 95% CI 0.17 to 0.94, p = 0.036). Though limited by a relatively small sample size and potentially confounded by anti-psychotic medications, this study suggests that the prevalence of atopy is lower in patients with schizophrenia. Replicating these results in larger samples could add to our growing understanding of immunological implications in mental illness.

    Citation: Olaoluwa Okusaga, Robert G. Hamilton, Adem Can, Ajirioghene Igbide, Ina Giegling, Annette M. Hartmann, Bettina Konte, Marion Friedl, Gloria M Reeves, Dan Rujescu, Teodor T. Postolache. Phadiatop Seropositivity in Schizophrenia Patients and Controls: A Preliminary Study[J]. AIMS Public Health, 2014, 1(2): 43-50. doi: 10.3934/publichealth.2014.2.43

    Related Papers:

    [1] Ming-Zhen Xin, Bin-Guo Wang, Yashi Wang . Stationary distribution and extinction of a stochastic influenza virus model with disease resistance. Mathematical Biosciences and Engineering, 2022, 19(9): 9125-9146. doi: 10.3934/mbe.2022424
    [2] Tingting Xue, Xiaolin Fan, Zhiguo Chang . Dynamics of a stochastic SIRS epidemic model with standard incidence and vaccination. Mathematical Biosciences and Engineering, 2022, 19(10): 10618-10636. doi: 10.3934/mbe.2022496
    [3] Fathalla A. Rihan, Hebatallah J. Alsakaji . Analysis of a stochastic HBV infection model with delayed immune response. Mathematical Biosciences and Engineering, 2021, 18(5): 5194-5220. doi: 10.3934/mbe.2021264
    [4] Kangbo Bao, Qimin Zhang, Xining Li . A model of HBV infection with intervention strategies: dynamics analysis and numerical simulations. Mathematical Biosciences and Engineering, 2019, 16(4): 2562-2586. doi: 10.3934/mbe.2019129
    [5] Yang Chen, Wencai Zhao . Dynamical analysis of a stochastic SIRS epidemic model with saturating contact rate. Mathematical Biosciences and Engineering, 2020, 17(5): 5925-5943. doi: 10.3934/mbe.2020316
    [6] Helong Liu, Xinyu Song . Stationary distribution and extinction of a stochastic HIV/AIDS model with nonlinear incidence rate. Mathematical Biosciences and Engineering, 2024, 21(1): 1650-1671. doi: 10.3934/mbe.2024072
    [7] H. J. Alsakaji, F. A. Rihan, K. Udhayakumar, F. El Ktaibi . Stochastic tumor-immune interaction model with external treatments and time delays: An optimal control problem. Mathematical Biosciences and Engineering, 2023, 20(11): 19270-19299. doi: 10.3934/mbe.2023852
    [8] Tianfang Hou, Guijie Lan, Sanling Yuan, Tonghua Zhang . Threshold dynamics of a stochastic SIHR epidemic model of COVID-19 with general population-size dependent contact rate. Mathematical Biosciences and Engineering, 2022, 19(4): 4217-4236. doi: 10.3934/mbe.2022195
    [9] Divine Wanduku . The stochastic extinction and stability conditions for nonlinear malaria epidemics. Mathematical Biosciences and Engineering, 2019, 16(5): 3771-3806. doi: 10.3934/mbe.2019187
    [10] Xiaomeng Wang, Xue Wang, Xinzhu Guan, Yun Xu, Kangwei Xu, Qiang Gao, Rong Cai, Yongli Cai . The impact of ambient air pollution on an influenza model with partial immunity and vaccination. Mathematical Biosciences and Engineering, 2023, 20(6): 10284-10303. doi: 10.3934/mbe.2023451
  • There is a dearth of information on the association of atopy with schizophrenia. The few available studies used population-based registers to classify the atopy status of the patients but this strategy is not reliable. This study measured seropositivity with a multiallergen screen of allergen specific IgE antibodies in schizophrenia patients versus healthy controls. A subset of 66 schizophrenia patients and 34 healthy controls were randomly selected from a large comparative study of schizophrenia patients and controls. The Phadiatop multi-allergen screen was performed on sera from all the participants to assess their atopic status. Logistic regression was used to calculate the odds ratio for the association of schizophrenia with Phadiatop seropositivity as a measure of atopy. The prevalence of Phadiatop seropositivity was significantly lower (χ2 4.59, p = 0.032) and there was a reduced odds ratio for atopy in schizophrenia patients relative to controls (OR 0.40; 95% CI 0.17 to 0.94, p = 0.036). Though limited by a relatively small sample size and potentially confounded by anti-psychotic medications, this study suggests that the prevalence of atopy is lower in patients with schizophrenia. Replicating these results in larger samples could add to our growing understanding of immunological implications in mental illness.


    Recently, Whitman and Jayaprakash [1] published a study of a simple, stochastic, agent-based model of influenza infection, Infectious diseases have been and continue to be a major public-health problem [2], disrupting people's quality of life and reducing their chances of survival. The appearance of new diseases and the repetition of mutant strains have added to their massive unhelpful blow. The control of the influenza virus, a foremost international health condition poses a scientific challenge at many levels. Influenza is caused by a virus. According to [3], it is characterized by a severe cytopathogenic respiratory disease that is infectious in nature. Based on matrix protein and nucleoprotein differences, it can be subdivide into A, B and C [4].

    Humans and animals are both infected with Types A and B. The most virulent type, i.e., the Type A virus which is now known as one of the most problematic viruses to tackle [5] is further classified based on the hemagglutinin and neuraminidase proteins located on the virus's surface. Hemagglutinin H1 to H16 and neuraminidase N1 to N9 are the two groups of proteins, the combination of which classifies the influenza subtypes. Influenza A's nomenclature is determined by a mix of hemagglutinin and neuraminidase. The H1N1 virus, for example, is influenza A with both H1 and N1 proteins; its spread is usually not epidemic, and that is why it is difficult to distinguish it from a regular cold [6].

    Another way to characterize them is by the influenza A and B strains [7]. New influenza strains emerge as a result of genetic changes or drift [8]. Antigenic drift is caused by progressive changes in the virus over time. Antibodies have a difficult time recognizing new strains. Antigenic shift, on the other hand, is characterized by fast changes in the virus that result in the emergence of a completely new strain. Influenza A can go through either of the modifications, whereas Influenza B only goes through antigenic drift [9,10].

    Vaccination is incapable of protecting against the new influenza strain. The 2009 H1N1 influenza pandemic showed this. Antivirals are thus required to halt the spread of the influenza outbreak [11]. Recently, incidences of influenza virus resistance have been discovered. The H3N2 virus resistance to aminoadamantanes and the H1N1 virus resistance to oseltamivir are two examples. Resistance is lethal and has the potential to create numerous pandemics in the future [12].

    When compared to the original strain, the transmission rate of a new strain is thought to be quite low. The fact that mutation reduces viral strength is linked to this phenomenon [13]. In the instance of H1N1 influenza virus resistance to oseltamivir, however, it was discovered that these alterations do not always affect virus transmission [14,15].

    For at least the last several centuries, the influenza virus has been responsible for periodic outbreaks of acute febrile illness every 1 to 4 years. The first influenza like sickness outbreak was documented in 1173 and 1174 [16], while the first true epidemic occurred in 1694. [17]. Between 1918 and 1919, the globe was struck by the worst epidemic in recorded history, with an estimated 21 million victims [18]. As indicated by records, it was one of the most terrible events in mankind's set of experiences. Three additional pandemics occurred in the 20th century, namely the 1957 H2N2 pandemic, the 1968 H3N2 pandemic and the 2009 flu A (H1N1) infection (pH1N1) pandemic.

    In the most famous model, a flu strain was found in Mexico and later in the United States of America with a blend of various qualities not recently seen in pig or human flu infection strains [19]. The pandemic was announced in August 2010 after the involvement of different zones [20].

    Young people have the highest rates of influenza infection, while older adults have the highest fatality rates. Mortality and morbidity are particularly high for those with certain high risk medical conditions, such as extreme aging, cardiovascular disorders and metabolic diseases such as diabetes mellitus. During the 2009 pandemic, there was an elevated risk of influenza morbidity and mortality in pregnant women [21]. Furthermore, evidence from prior pandemic and seasonal influenza outbreaks suggests that the risk of influenza complications is higher in the second half of pregnancy than in the first.

    To investigate the influence of environmental conditions on influenza transmission and make the results more realistic, we first developed a stochastic mathematical influenza model. Following that, the factors required for extinction and persistence were analyzed. The threshold of the suggested stochastic influenza model has also been established. When there is tiny or large noise, it plays a critical role in the mathematical models as a backbone [22,23]. Finally, we visualized the numerical simulations using MATLAB.

    In this section, we provide our new stochastic influenza model in the form of differential equations.

    ● The total inhabitant $ \aleph(t) $ is distributed in four compartment, i.e., $ \mathcal{S}_t $, $ \mathcal{I}_{N_t} $, $ \mathcal{I}_{R_t} $ and $ \mathcal{R}_t $, which represent the susceptible and infected people with resistance, infected peoples with non-resistance and recovered people respectively.

    ● The variables and parameters of the proposed stochastic model are non-negative.

    ● We deliberate that the variability of $ \mu $ and $ \gamma $ is subject to stochastic white noise disturbance, i.e., $ \mu\rightarrow \mu+\sigma_1B_1(t) $ and $ \gamma\rightarrow \gamma+\sigma_2B_2 $; where $ B_1(t) and B_2(t) $ represent the Brownian motion with the property $ B_1(0) = 0 = B_2(0) $ and the intensities $ \sigma^2_1 and \sigma^2_2 $ are positive.

    Remark 2.1. The deterministic general epidemic study estimates that if $ {{\underset{\scriptscriptstyle\centerdot}{{R}}}}{_r} < 1 $, a small outburst will arise, and if $ {{\underset{\scriptscriptstyle\centerdot}{{R}}}}{_r} > 1 $, a large outbreak will occur, infecting a large chunk of the populace. The results are based on the assumption that the community is homogeneous and that individuals mingle evenly. However, if the hypothesis of an evenly mixed society is accepted, this model may not be appropriate in particular situations. When contemplating a tiny population, such as an epidemic outbreak in a daycare center or school, it appears logical to presume that the eventual number of infected will be unpredictable or random. Also, even if $ {{\underset{\scriptscriptstyle\centerdot}{{R}}}}{_r} > 1 $ and the society is huge, if the outbreak is started by only one (or a few) early infectives, the epidemic may never take off by accident. The formulation of a related stochastic epidemic model is motivated by these two aspects. It allows parameter estimations from disease outbreak data to include standard errors, and the subject of disease extinction is better suited for stochastic models for researching epidemic diseases.

    In light of the above speculations, we established the following new stochastic influenza model;

    $ dS=(bdSSINαSβIRkIR+1)dt,dIN=(αSIN(μ+d)IN)dtσ1INdB1(t),dIR=(βSIRkIR+1(γ+d)IR)dtσ2IRdB2(t),dR=(μIN+γIRdR)dt+σ1INdB1(t)+σ2IRdB2(t). $ (2.1)
    Table 1.  Parametric description of the model.
    Symbol Description Value
    $ \alpha $ The rate of infection by a non-resistant strain 0.15
    $ \beta $ The rate of infection by a resistant strain 0.10
    $ \gamma $ The rate at which resistant individuals are eliminated from the inhabitants 0.75
    $ \mu $ Represents the pace at which non-resistant strains are evicted from the population 0.80
    $ b $ Denotes recruitment into the susceptible group 1.00
    $ d $ The death rate 0.20
    $ k $ The effect of mutation on the resistant strain 0.10

     | Show Table
    DownLoad: CSV

    Also, we have the compartment table below:

    Table 2.  Compartments and description.
    Symbol Description Value
    $ \mathcal{S} $ Susceptible 20
    $ \mathcal{I}_N $ Infected peoples with resistance 2
    $ \mathcal{I}_R $ Infected peoples with non-resistance 2
    $ \mathcal{R} $ Recovered peoples 1

     | Show Table
    DownLoad: CSV

    The authors of [24] developed the following deterministic model:

    $ dSdt=bdSαSINSIRβkIR+1,dINdt=αSIN(d+μ)IN,dIRdt=βSIRkIR+1(d+γ)IR,dRdt=μIN+γIRdR, $ (2.2)

    and

    $ d(t)=bdt $ (2.3)

    where $ \aleph_t\quad = \quad\mathcal{S}_t+\mathcal{I}_{N_t}+\mathcal{I}_{R_t}+\mathcal{R}_t $ indicates all the constant residents for $ b\approx\mu\aleph $ and $ \aleph_0\quad = \quad\mathcal{S}_0+\mathcal{I}_{N_0}+\mathcal{R}_0+\mathcal{I}_{R_0} $. Equation (2.3) has the exact solution

    $ t=edt[0+bdedt] $ (2.4)

    Also we have $ 0\geq\mathcal{I}_{N_0}, 0\geq\mathcal{S}_0, \mathcal{I}_{R_0}\geq0, \mathcal{R}_0\geq0\Rightarrow \mathcal{I}_{N_t}\geq0, \mathcal{S}_t\geq0, \mathcal{I}_{R_t}\geq0\; and\; \mathcal{R}_t\geq0 $, so the result has a positivity property. If $ {{\underset{\scriptscriptstyle\centerdot}{\text{R}}}}{_r} < 1 $ then the model (2.2) will be locally stable and unstable otherwise. Similarly for $ b = 0 $ the model (2.2) will be globally asymptotically stable.

    In this article, we will establish the computational and analytical aspects of the stochastic influenza model, and we will mathematically correlate our results with the deterministic model for future forecasts by using various parametric variables. As a result, this research can help the local community become more aware of the disease's spread.

    Here, we made the following speculations:

    ● $ \mathbb{R}^\texttt{d}_+ = \{\varsigma\in\mathbb{R}^\texttt{d}: 0 < \varsigma_i, \texttt{d} > 1 \} $.

    ● Suppose a complete probability space $ (\Omega^\circledast, \Im^\circledast, \{\Im^\circledast_t\}_{t\geq0}, \mathcal{P}^\circledast) $ with filtration $ \{\Im^\circledast_t\}_{t\geq0} $ satisfies the usual condition.

    We reflect a common four-dimensional stochastic differential equation for the existence of the solution of our model which is described by (2.1):

    $ dς(t)=Θ(ς(t),t)dt)+Θ(ς(t),t)dB(t)),fort=t0 $ (3.1)

    with the initial condition $ \varsigma(t_0) = \varsigma_0\in\mathbb{R}^\texttt{d} $. By defining the differential operator $ {\rm{Ł}}^\star $ using (3.1), we get

    $ Ł=t+4i=1Θi(ς,t)ςi+125i,j=1[ΘT(ς,t)ΘT(ς,t)]ij(2ςiςj). $ (3.2)

    If $ {\rm{Ł}}^\star $ acts on the function $ \mathcal{V}^\star = (\mathbb{R}^\texttt{d}\times\mathbb{\tilde{R}_+}; \mathbb{\tilde{R}_+}) $, then

    $ ŁV(ς,t)=Vt(ς,t)+Vς(ς,t)Θ(ς,t)+12trace[ΘT(ς,t)Vςς(ς,t)Θ(ς,t)]. $ (3.3)

    In this section, our discussion will be on the solution of the stochastic influenza model (2.1).

    Theorem 4.1. There is a unique positive solution $ (\mathcal{I}_{N_t}, \mathcal{S}_t, \mathcal{I}_{R_t}, \mathcal{R}_t) $ of the system $(2.1)$ for $ t\geq 0 $ with $ (\mathcal{I}_{N_0}, \mathcal{S}_0, \mathcal{I}_{R_0}, \mathcal{R}_0)\in \mathbb{R}_+^4 $, and the solution will be left in $ \mathbb{R}_+^4 $, with a probability equal to one.

    Proof. Because (2.1) satisfies the local Lipschitz condition [25], formally for $ (\mathcal{I}_{N_t}, \mathcal{S}_t, \mathcal{I}_{R_t}, \mathcal{R}_t)\in \mathbb{R}_+^4 $, we do have $ (\mathcal{I}_{N_t}, \mathcal{S}_t, \mathcal{I}_{R_t}, \mathcal{R}_t)\in \mathbb{R}_+^4 $ a distinctive local solution on $ t\in[0, \tau_e) $, where $ \tau_e $ is the flare-up time. Next, our aim is to show $ \tau_e = \infty $ for the global solution of (2.1). Assume $ 0\leq \ell_0 $ is very large so that $ (\mathcal{I}_{N_0}, \mathcal{S}_0, \mathcal{I}_{R_0}, \mathcal{R}_0) $ lies in $ [\frac{1}{\ell_0}, \ell_0] $. For $ \ell_0\leq \ell $, define

    $ τ=inf{t[0,τe):1min{(INt,St,IRt,Rt)} or max{(INt,St,IRt,Rt)}}. $

    Let $ \inf\emptyset = \infty $ (because typically $ \emptyset $ is the empty set). Since $ \tau_\ell $ is increasing for $ \ell\rightarrow \infty $, let $ \tau_\infty = lim_{\ell\rightarrow \infty}\tau_\ell $; then, we have $ \tau_\infty\leq\tau_e $ almost surely. Next, we need to confirm $ \tau_\infty = \infty $ a.s. If this assertion is incorrect, then there exist a constant $ \mathcal{T} > 0 $ and $ \in (0, 1) $ such that $ \mathbb{P}\{\tau_\infty\leq \mathcal{T}\} > \in $. As a consequence, we have $ \ell_1\geq \ell_0 $ such that

    $ P{τT}≥∈,k1fortτ. $ (4.1)

    We outline a $ \mathbb{C}^2 $-function $ U:\mathbb{R}^4_+\rightarrow \mathbb{R}_+ $ by using the resulting formulation

    $ U(INt,St,IRt,Rt)=(Stc_~c_~lnStc_~)+(INt(34+14)lnINt)+(IRt(34+14)lnIRt)+(Rt(34+14)lnRt). $ (4.2)

    Obviously the function $ U $ is non-negative which can follow from $ {z}-(\frac{3}{4}+\frac{1}{4})-\log z \geq 0\quad \forall \quad z > 0 $. Suppose $ \ell\geq \ell_0 $ and $ \mathcal{T}\geq0 $ are arbitrary. Applying Ito's formula to (4.2) we get

    $ dU(INt,St,IRt,Rt)=(11INt)dINt+12I2Nt(dINt)2+(11IRt)dIRt+12I2Rt(dIRt)2+(11Rt)dRt+12R2t(dRt)2+(1c_~St)dSt $ (4.3)
    $ =ŁU(INt,St,IRt,Rt)+σ1(INtSt)dB1(t)+σ2(IRtSt)dB2(t), $ (4.4)

    where $ {\rm{Ł}}^\star U:\mathbb{R}^4_+\rightarrow \mathbb{R}_+ $ is defined by

    $ ŁU(INt,St,IRt,Rt)=(1c_~St)(bdStαStINtStβIR1+kIRt)+(11INt)(αStINt(d+μ)INt)+12σ21+(11IRt)(βStIRt1+kIRt(d+r)IRt)+12σ22+(11Rt)(μINt+γIRtdRt)+12σ21+12σ22=bdStαStINtβStIRt1+kIRtc_~bSt+c_~d+c_~αINt+c_~βIRt1+kIRt+αStINt+(d+γ)INtαSt+(d+μ)+StβIRt1+kIRt(d+γ)IRt+(d+γ)βSt1+kIRt+μINt+γIRtdRtγ+dμINtRt+σ21+σ22bdStαStINt+c_~d+c_~αINt+αStINt+(d+γ)INtαSt+(2d+μ+γ)dIRtγIRt+μINt+γIRtdRtγ+d+σ21+σ22b+c_~d+c_~αINt+αStINt+(d+γ)INt+(d+γ)+γIRt+μINt+d+σ21+σ22B. $ (4.5)

    Thus, we have

    $ ˉE[U(St(τȷ),(INt(τȷ),(IRt(τȷ),(R(τȷ)]U(S0,IN0,IR0,R0+ˉE[τȷ0Kdt]U(S0,IN0,IR0,R0)+K. $ (4.6)

    We consider that $ \Omega_\jmath = \{\sigma_\jmath\leq \rightthreetimes\} $ for all $ \jmath\geq \jmath_1 $ and by (2.3), $ P(\Omega_\jmath)\geq\epsilon $. We comment that for every $ \omega\in\Omega_\jmath $ there exist at least $ \mathcal{S}_t(\tau_\jmath, \omega), \mathcal{I}_{N_t}(\tau_\jmath, \omega), \mathcal{I}_{R_t}(\tau_\jmath, \omega)\; and\; \mathcal{R}(\tau_\jmath, \omega) $, equaling the value $ \jmath $ or $ \frac{1}{\jmath} $ then we get that $ U(\mathcal{S}_t(\tau_\jmath), \mathcal{I}_{N_t}(\tau_\jmath), \mathcal{I}_{R_t}(\tau_\jmath), \mathcal{R}(\tau_\jmath)) $ is not less than $ \jmath-1-\log\jmath $ or $ (\frac{1}{\jmath})-1+\log\jmath. $ Accordingly,

    $ U(St(τȷ),INt(τȷ),IRt(τȷ),R(τȷ))ˉE(ȷ1logȷ)(1ȷ)1+logȷ). $ (4.7)

    From (4.1) and (4.6), we get the following relation

    $ U(S0,IN0,IR0,R0)+KˉE[1ΩȷU(St(τȷ),INt(τȷ),IRt(τȷ),Rt(τȷ))]ξ[(ȷ1logȷ)((1ȷ)1+logȷ)], $ (4.8)

    where $ 1_{\Omega_\jmath} $ denotes the indicator function. We observe that $ k\rightarrow \infty $ leads to the ambiguity $ \infty > U(\mathcal{S}_0, \mathcal{I}_{N_0}, \mathcal{I}_{R_0}, \mathcal{R}_0)+\mathcal{M^\prime}\rightthreetimes = \infty $, which implies that $ \tau_\infty = \infty $ a.s.

    In this part, we determine when the sickness will be cured and when it will be revived. As a result, the system's (2.1) vital reproduction is demonstrated. Based on the proof in [26], we can deduce the subsequent lemmas:

    Lemma 5.1. Let $ (\mathcal{S}_t, \mathcal{I}_{N_t}, \mathcal{I}_{R_t}, \mathcal{R}_t) $ be the solution of the model $(2.1)$ with the initial values given by $ (\mathcal{S}_0, \mathcal{I}_{N_0}, \mathcal{I}_{R_0}, \mathcal{R}_0)\in\mathbb{R}^4_+ $, ; then, $ \lim_{t\rightarrow \infty}\frac{\mathcal{I}_{N_t}+\mathcal{S}_t+\mathcal{I}_{R_t}+\mathcal{R}_t}{t} = 0 $ is almost certain.

    In fact, together with the positivity of the solution and the system (2.1), we have that $ \lim_{t\rightarrow \infty}\frac{\mathcal{S}_t}{t} = 0 $ $ \lim_{t\rightarrow \infty}\frac{\mathcal{I}_{N_t}}{t} = 0 $, $ \lim_{t\rightarrow \infty}\frac{\mathcal{I}_{R_t}}{t} = 0 $ and $ \lim_{t\rightarrow \infty}\frac{\mathcal{R}_t}{t} = 0 $ a.s.

    Lemma 6.1. Suppose $ d > (\frac{1}{2}\sigma^2_1\vee\frac{1}{2}\sigma^2_2) $. Assume $ (\mathcal{S}_t, \mathcal{I}_{N_t}, \mathcal{I}_{R_t}, \mathcal{R}_t) $ is the solution of the model $(2.1)$ with initial values given by $ (\mathcal{S}_0, \mathcal{I}_{N_0}, \mathcal{I}_{R_0}, \mathcal{R}_0)\in\mathbb{R}^4_+ $; then,

    $ limtt0IR(s)dB2(s)t=0,limtt0IN(s)dB1(s)t=0. $ (6.1)

    Let

    $ Rr=αbd(d+μ+12σ21)=Rrαb2d(d+μ)(d+μ+12σ21)σ21, $

    where

    $ Rr=αbd(d+μ) $ (6.2)

    is the deterministic model's fundamental reproduction number.

    In this segment, we scrutinize the condition for the disappearance of the influenza model (2.1), we lead with the following representation and definition. Let $ \langle \jmath(t)\rangle = \frac{1}{t}\int_0^t \jmath(r)dr $, then the following are the outcomes for the disease's termination.

    Theorem 7.1. Let $ (\mathcal{S}_t, \mathcal{I}_{N_t}, \mathcal{R}, \mathcal{I}_{R_t}) $ be the solution of the stochastic influenza model $(2.1)$, with the initial values given by $ (\mathcal{S}_0, \mathcal{I}_{N_0}, \mathcal{R}_0, \mathcal{I}_{R_0})\in \Omega^\odot $. If $ R_r < 1 $ then $ \lim_{t\rightarrow \infty}(\frac{\log\mathcal{I}_{N_t}}{t}) < 0 $ $ \quad $ and $ \quad $ $ \lim_{t\rightarrow \infty}(\frac{\log\mathcal{I}_{R_t}}{t}) < 0 $; almost surely, $ \mathcal{I}_{N_t}\rightarrow 0 $ and $ \mathcal{I}_{R_t}\rightarrow 0 $ exponentially a.s which means that the disease terminates with a probability of one). Also $ \lim_{t\rightarrow \infty}\int_0^t\mathcal{S}_t = (\frac{b}{d}) $, $ \quad $ $ \lim_{t\rightarrow \infty}\mathcal{I}_{N_t}(t)(t) = 0 $, $ \quad $ $ \lim_{t\rightarrow \infty}\mathcal{I}_{R_t}(t) = 0 $ and $ \quad $ $ \lim_{t\rightarrow \infty}\int_0^t\mathcal{R}_t(t) = 0 $.

    Proof. After integrating (2.1), we can get the following system of equations

    $ StS0t=bdStαStINtβStIRt1+kIRt,INtIN0t=αStINt(d+μ)INt1tσ1t0INt(r)dB1(r),IRtIR0t=βStIRt1+kIRt(d+γ)IRt1tσ2t0IRt(r)dB2(r),RtR0t=μINt+γIRtdR+1tσ1t0INt(r)dB1(r)+1tσ2t0IRt(r)dB2(r), $ (7.1)
    $ StS0t+INtIN0t+IRtIR0t+RtR0t=bdStdINtdIRtdR, $ (7.2)
    $ St=bdINtIRtRt+Φ(t), $ (7.3)

    where

    $ Φ(t)=1d[StS0t+INtIN0t+IRtIR0t+RtR0t] $ (7.4)

    Obviously $ \Phi(t)\rightarrow 0 $ as $ t\rightarrow \infty $. Applying Ito's formula to the second equation of (2.1) gives

    $ dlogINt=(αSt(d+μ)+12σ21)dtσ1dB1(t) $ (7.5)

    If we Integrate (7.5) from $ 0 $ to $ t $ and divide by $ t $, we get

    $ logINtlogIN0t=αSt(d+μ)+12σ211tσ1t0dB1(r) $ (7.6)

    Substituting (7.3) in (7.6), we have

    $ logINtlogIN0t=α[bdINtIRtRt+Φ(t)](d+μ)+12σ211tσ1t0dB1(r)αbd(d+μ)+12σ21αINtαIRtαRt1tσ1t0dB1(r)+Φ(t)=(d+μ12σ21)(1Rr)αINtαIRtαRt+, $ (7.7)

    where

    $ =Φ(t)1tσ1t0dB1(r). $ (7.8)

    For $ \daleth = 0 $ and $ t\rightarrow \infty $, we have

    $ limtsuplogINtt(d+μ12σ21)(1Rr)αINtαIRtαRt. $ (7.9)

    Equation (7.9) implies that

    $ limtINt=0. $ (7.10)

    Similarly, it may also be proved that

    $ limtIRt=0. $ (7.11)

    Now for $ \mathcal{S}_t $, we have the following from the first equation of the model (2.1)

    $ StS0t=bdt0Stdtαt0StINtdtt0βStINt1+kIRt,dt0Stdt=bαt0StINtdtt0βStINt1+kIRtStS0t,t0Stdt=bdαdt0StINtdtt0βdStINt1+kIRt1b(StS0t). $ (7.12)

    This implies that $ \lim_{t\rightarrow \infty}\int_0^t\mathcal{S}_t = \frac{b}{d} $. Now from the fourth equation of the system (2.1), it follows that

    $ Rt=edt[R0+t0μIN(r)edt+t0γIR(r)edt]. $ (7.13)

    By applying the L'Hospital's rule to the above result, we get

    $ limtt0Rdt=0, $ (7.14)

    which completes the proof.

    In this section, we will investigate the necessary conditions for the persistence of the disease.

    Theorem 8.1. Assume $ d > (\frac{1}{2}\sigma^2_1\vee\frac{1}{2}\sigma^2_2) $. Let $ (\mathcal{S}_t, \mathcal{I}_{N_t}, \mathcal{I}_{R_t}, \mathcal{R}_t) $ be the solution of the stochastic influenza model $(2.1)$, with the initial values given by $ (\mathcal{S}_0, \mathcal{I}_{N_0}, \mathcal{I}_{R_0}, \mathcal{R}_0)\in\mathbb{R}^4_+ $. If $ R^\star_r > 1 $, then

    $ limtt0S(s)ds=bdRra.s,limtt0IN(s)ds=d(d+μ+12σ21)α(d+μ)(Rr1)a.s.,limtt0R(s)ds=μ(d+μ+12σ21)α(d+μ)(Rr1)a.s.,limtt0IR(s)ds=[d(d+μ+12σ21)((d+μ+12σ21)(d+γ+12σ21)αd))αdk(d+γ(bαd(d+μ+12σ21)))](Rr1)a.s. $

    Proof. If $ \mathcal{R}^\star_r > 1 $, then by (7.9) and Lemmas 5.1 and 5.2 in [27], we have

    $ limtt0IN(s)ds=bαd(d+μ+12σ21)α(d+μ)d=d(d+μ+12σ21)d+μ(Rr1). $ (8.1)
    $ limtt0S(s)ds=bdd+μ+12σ21α(Rr1)=bdRr. $

    Now from the fourth equation of model (2.1), we obtain

    $ RtR0t=μtt0IN(s)ds+γtt0IR(s)dsdtt0R(s)ds+σ1tt0IN(s)dB1(s)+σ2tt0IR(s)dB1(s),1tt0R(s)ds=μtt0IN(s)ds+ð, $ (8.2)

    where

    $ ð=γtt0IR(s)dsdtt0R(s)ds+σ1tt0IN(s)dB1(s)+σ2tt0IR(s)dB1(s)RtR0t, $

    $ \eth(t) $ has the property that

    $ limtð=0. $ (8.3)

    By substituting (8.1) in (8.2), we have

    $ limtt0R(s)ds=μ(d+μ+12σ21)α(d+μ)(Rr1). $

    Now from the third equation of the model (2.1), using Ito's formula yields

    $ d(lnIRtkIRt)=[βSt(d+γ)k(d+γ)IRt12σ22]dt+σ2dB2(s). $ (8.4)

    Integrating (8.4) from $ 0 $ to $ t $, we have

    $ lnIRtIR0t+k(IRtIR0t)=βtt0S(s)ds(d+γ+12σ22)k(d+γ)tt0IR(s)ds+1tt0σ2dB2(s)=bβdRrk(d+γ)tt0IR(s)ds+1tt0σ2dB2(s)(d+γ)12σ22k(d+γ)tt0IR(s)ds=bβdRr+1tt0σ2dB2(s)(d+γ)12σ22[lnIRtIR0t+k(IRtIR0t)], $
    $ 1tt0IR(s)ds=1k(d+γ)[bβdRr12σ22(d+γ)+(s)], $ (8.5)

    where $ \curlywedge(s) = \frac{1}{t}\int_0^t\sigma_2dB_2(s)-(\frac{\ln\mathcal{I}_{R_t}-\mathcal{I}_{R_0}}{t}+k(\frac{\mathcal{I}_{R_t}-\mathcal{I}_{R_0}}{t}) $; $ \eth(t) $ has the property that

    $ limt(s)=0. $ (8.6)

    Taking the limit of (8.5) and incorporating the value $ \mathcal{R}^\star_r $ we have

    $ limtt0IR(s)ds=[d(d+μ+12σ21)((d+μ+12σ21)(d+γ+12σ21)αd))αdk(d+γ(bαd(d+μ+12σ21)))](Rr1)a.s. $

    This completes the proof.

    We have accomplished our analysis of disease extinction and persistence. We will now perform some numerical simulations of (2.1) to illustrate the applicability of our findings. The Milstein technique [28] was used to generate the numerical simulations. Consider the model's discretization equation:

    $ Sk+1=Sk+(bdSkαSkINkβSkIRk1+kIRk)Δt,INk+1=INk+(αSkINk(d+μ)INk)Δtσ1INkΔtτkσ212INk(τ2k1)Δt,IRk+1=IRk+(βSkIRk1+kIRk(d+γ)IRk)Δtσ2IRkΔtτkσ222IRk(τ2k1)Δt,Rk+1=Rk+(μINk+γIRkdRk)Δt+σ1INkΔtτk+σ212INk(τ2k1)Δt,+σ2IRkΔtτk+σ222IRk(τ2k1)Δt. $

    Here, we shall discuss the graphical description of the model (2.1). In Figure 1, we have illustrated a numerical solution of the model (2.1) and those obtained in comparative studies of all the classes for the white noise values $ \sigma_1 = \sigma_2 = 0.0, \, 0.05, \, 0.10, \, 0.12 $ and $ S(0) = 20, \, I_N(1) = 2, \, I_R(1) = 2, \, R(1) = 1 $, $ b = 1.00, \, d = 0.20, \, \alpha = 0.15, \, \mu = 0.80, \, \beta = 0.10, \, \gamma = 0.75, \ and\; k = 0.10 $. In Figure 2, we have illustrated a numerical solution of the model (2.1) and those obtained in comparative studies of all the classes for the white noise values $ \sigma_1 = \sigma_2 = 0.0, \, 0.05, \, 0.10, \, 0.12 $ and $ S(0) = 20, \, I_N(1) = 2, \, I_R(1) = 2, \, R(1) = 1 $, $ b = 1.00, \, d = 0.20, \, \alpha = 0.60, \, \mu = 0.20, \, \beta = 0.10, \, \gamma = 0.75, \ and\; k = 0.10 $. We have observed that there is an important role in the dynamics of the values for $ \alpha $ and $ \mu $. As $ \alpha $ was increased from $ 0.15 $ to $ 0.60 $ and $ \mu $ was decreased from $ 0.80 $ to $ 0.20 $, we observed a rapid fall in the susceptible class and $ I_N $ increased for the cases with the white noise and without white noise. In this case the recovery rate also increased. The role of white noise has presented a change in the dynamics more accurately. Figure 3 represents the joint solutions for the model (2.1) at zero noise for different values of $ \mu $ and $ \alpha $. The left side corresponds to $ \mu = 0.80 $ and $ \alpha = 0.15 $ while the right side graphs show the joint solution at $ \mu = 0.15 $ and $ \alpha = 0.60 $. This change shows a clear difference in the dynamics.

    Figure 1.  Numerical results for the model (2.1) at $ \sigma_1 = \sigma_2 = 0.0, \, 0.05, \, 0.10, \, 0.12 $.
    Figure 2.  Numerical results for the model (2.1) at $ \sigma_1 = \sigma_2 = 0.0, \, 0.05, \, 0.10, \, 0.12 $.
    Figure 3.  Joint solution of the model (2.1) at zero noise.

    In this work, we have explored the dynamic behavior of an $ \mathcal{S}\mathcal{I}_N\mathcal{I}_R\mathcal{R} $ influenza stochastic model that ponders the effects of information interference and environmental noise. Information interventions and white noise have been discovered to have a significant impacts on the condition. Hereafter, we present our primary findings.

    We have measured the effects of environmental white noise on the disease. We have shown that $ {{\underset{\scriptscriptstyle\centerdot}{\text{R}}}}{_r} $ is a threshold of the model (2.1) for the disease to die out or persist, and that noise strength can change the value of the stochastic reproduction number $ {{\underset{\scriptscriptstyle\centerdot}{\text{R}}}}{_r} $. If $ {{\underset{\scriptscriptstyle\centerdot}{\text{R}}}}{_r} < 1 $, the disease will die out with a probability of one. On the other hand, if $ {{\underset{\scriptscriptstyle\centerdot}{\text{R}}}}{_r} > 1 $, there is a stationary distribution for the model (2.1), which means that the disease will prevail. The discretization approach was used to construct a numerical scheme for the model simulations. The results of the simulations are presented throughout the article in the form of graphs that are divided into three sections. In Figure 2, we have shown a numerical solution of the model (2.1) as well as those obtained in comparative studies of all classes for the white noise values $ \sigma_1 = \sigma_2 = 0.0, \, 0.05, \, 0.10, \, 0.12 $ and $ S(0) = 20, \, I_N(0) = 2, \, I_R(0) = 2, \, R(0) = 1 $, $ b = 1.00, \, d = 0.20, \, \alpha = 0.60, \, \mu = 0.20, \ and\; \beta = 0.10 $. We have seen that the dynamics of the values for $ \alpha $ and $ \mu $ play an essential role. We noticed a rapid fall in the susceptible class as the $ \alpha $ value was increased from $ 0.15 $ to $ 0.60 $ and $ \mu $ dropped from $ 0.80 $ to $ 0.20 $; additionally, $ I_N $ was increased for both instances with and without white noise. The healing rate was also boosted in this instance. White noise has played a larger role in influencing the dynamics.

    The joint solutions for the model (2.1) at zero noise are shown in figure 3 for different values of $ \mu $ and $ \alpha $. The left side graphs correspond to $ \mu = 0.80 $ and $ \alpha = 0.15 $, whereas the right side graphs correspond to $ \mu = 0.15 $ and $ \alpha = 0.60 $ for the combined solution. This shift reveals a significant shift in the dynamics.

    J. Alzabut is thankful to Prince Sultan University and OSTİM Technical University for their endless support. G. Alobaidi was supported by Faculty research grant from the American University of Sharjah (Project number FRG21-S-S05).

    The authors declare there is no conflict of interest.

    [1] Novak N, Bieber T. (2003) Allergic and nonallergic forms of atopic diseases. J Allergy Clin Immunol. 112: 252-262. doi: 10.1067/mai.2003.1595
    [2] Strachan DP. (1989) Hay fever, hygiene, and household size. BMJ. 299: 1259-1260. doi: 10.1136/bmj.299.6710.1259
    [3] Raison CL, Lowry CA, Rook GA. (2010) Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression. Arch Gen Psychiatry. 67: 1211-1224. doi: 10.1001/archgenpsychiatry.2010.161
    [4] Schwarz MJ, Müller N, Riedel M, Ackenheil M. (2001) The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms. Med Hypotheses. 56: 483-486. doi: 10.1054/mehy.2000.1203
    [5] Laursen TM, Munk-Olsen T, Vestergaard M. (2012) Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry. 25: 83-88. doi: 10.1097/YCO.0b013e32835035ca
    [6] Smith DJ, Langan J, McLean G, Guthrie B, Mercer SW. (2013) Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: cross-sectional study. BMJ Open. 3(4): doi: 10. 1136/bmjopen-2013-002808.
    [7] Stahl SM, Morrissette DA, Citrome L, et al. (2013) “Meta-guidelines” for the management of patients with schizophrenia. CNS Spectr. 18: 150-162. doi: 10.1017/S109285291300014X
    [8] Hasan A, Falkai P, Wobrock T, et al. (2012) WFSBP Task force on Treatment Guidelines for Schizophrenia. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic induced side effects. World J Biol Psychiatry. 14:2-44.
    [9] Manalai P, Hamilton RG, Langenberg P, et al. (2012) Pollen-specific immunoglobulin E positivity is associated with worsening of depression scores in bipolar disorder patients during high pollen season. Bipolar Disord. 14: 90-98. doi: 10.1111/j.1399-5618.2012.00983.x
    [10] Postolache TT, Mortensen PB, Tonelli LH, et al. (2010) Seasonal spring peaks of suicide in victims with and without prior history of hospitalization for mood disorders. J Affect Disord. 121:88-93. doi: 10.1016/j.jad.2009.05.015
    [11] Woo JM, Okusaga O, Postolache TT (2012) Seasonality of suicidal behavior. Int J Environ Res Public Health. 9: 531-547. doi: 10.3390/ijerph9020531
    [12] Postolache TT, Stiller JW, Herrell R, et al. (2005) Tree pollen peaks are associated with increased nonviolent suicide in women. Mol Psychiatry. 10: 232-235. doi: 10.1038/sj.mp.4001620
    [13] Qin P, Waltoft BL, Mortensen PB, Postolache TT. (2013) Suicide risk in relation to air pollen counts: a study based on data from Danish registers. BMJ Open. 3(5): doi:10. 1136/bmjopen-2012-002462.
    [14] Tonelli LH, Hoshino A, Katz M, Postolache TT. (2008) Acute Stress Promotes Aggressive-Like Behavior in Rats Made Allergic to Tree Pollen. Int J Child Health Hum Dev. 1: 305-312.
    [15] Tonelli LH, Katz M, Kovacsics CE, et al. (2009) Allergic rhinitis induces anxiety-like behavior and altered social interaction in rodents. Brain Behav Immun. 23: 784-793. doi: 10.1016/j.bbi.2009.02.017
    [16] Tonelli LH, Stiller J, Rujescu D, et al. (2008) Elevated cytokine expression in the orbitofrontal cortex of victims of suicide. Acta Psychiatr Scand. 117:198-206. doi: 10.1111/j.1600-0447.2007.01128.x
    [17] Weber NS, Cowan DN, Millikan AM, Niebuhr DW. (2009) Psychiatric and general medical conditions comorbid with schizophrenia in the National Hospital Discharge Survey. Psychiatr Serv. 60: 1059-1067. doi: 10.1176/ps.2009.60.8.1059
    [18] Chen YH, Lee HC, Lin HC. (2009) Prevalence and risk of atopic disorders among schizophrenia patients: a nationwide population based study. Schizophr Res. 108: 191-196. doi: 10.1016/j.schres.2008.12.021
    [19] Pedersen MS, Benros ME, Agerbo E, Børglum A, Mortensen PB. (2012) Schizophrenia in patients with atopic disorders with particular emphasis on asthma: a Danish population-based study. Schizophr Res. 138: 58-62. doi: 10.1016/j.schres.2012.02.019
    [20] Szefler SJ, Wenzel S, Brown R, et al. (2012) Asthma outcomes: biomarkers. J Allergy Clin Immunol. 129: S9-S23. doi: 10.1016/j.jaci.2011.12.979
    [21] First MB, Spitzer RL, Gibbon M, Williams JBW. (2002) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. (SCID-I/P), Biometrics Research, New York, USA.
    [22] Okusaga O, Yolken RH, Langenberg P, et al. (2013) Elevated gliadin antibody levels in individuals with schizophrenia. World J Biol Psychiatry. 14:509-515. doi: 10.3109/15622975.2012.747699
    [23] Matsson P, Hamilton RG, Esch RE, et al. (2009) Analytical performance Characteristics and Clinical Utility of immunological assays for human immunoglobulin E (IgE) antibody of defined allergen specificities: 2 Eds, Pennsylvania:Clinical Laboratory Standards Institute.
    [24] Hamilton RG. (2008) Human immunoglobulins in Handbook of Human Immunology, A. D. Donnenberg, M. O'Gorman Eds. , 2Eds, Boca Raton: CRC Press, 63-106.
    [25] Miller BJ, Buckley P, Seabolt W, Mellor A, Kirkpatrick B. (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 70:663-671. doi: 10.1016/j.biopsych.2011.04.013
    [26] Brown AS, Patterson PH. (2011) Maternal infection and schizophrenia: implications for prevention. Schizophr Bull. 37: 284-290. doi: 10.1093/schbul/sbq146
    [27] Yudofsky SC. (2009) Contracting schizophrenia: lessons from the influenza epidemic of 1918–1919. JAMA. 301:
    [28] Karmaus W, Arshad H, Mattes J. (2001) Does the sibling effect have its origin in utero? Investigating birth order, cord blood immunoglobulin E concentration, and allergic sensitization at age 4 years. Am J Epidemiol. 154: 909-915.
    [29] Torrey EF, Bartko JJ, Lun ZR, Yolken RH. (2007) Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull. 33:
    [30] Fernandes JF, Taketomi EA, Mineo JR, et al. (2010) Antibody and cytokine responses to house dust mite allergens and Toxoplasma gondii antigens in atopic and non-atopic Brazilian subjects. Clin Immunol. 136: 148-156. doi: 10.1016/j.clim.2010.02.019
    [31] Ellertsen LK, Hetland G, Løvik M. (2008) Specific IgE to respiratory allergens and IgG antibodies to Toxoplasma gondii and Streptococcus pneumoniae in Norwegian military recruits. Scand J Immunol. 67: 496-500. doi: 10.1111/j.1365-3083.2008.02090.x
  • This article has been cited by:

    1. Abdulwasea Alkhazzan, Jungang Wang, Yufeng Nie, Khalid Hattaf, A New Stochastic Split-Step θ-Nonstandard Finite Difference Method for the Developed SVIR Epidemic Model with Temporary Immunities and General Incidence Rates, 2022, 10, 2076-393X, 1682, 10.3390/vaccines10101682
    2. Lassaad Mchiri, Ulam–Hyers stability of fractional Itô–Doob stochastic differential equations, 2023, 0170-4214, 10.1002/mma.9287
    3. J. Pradeesh, V. Vijayakumar, On the Asymptotic Stability of Hilfer Fractional Neutral Stochastic Differential Systems with Infinite Delay, 2024, 23, 1575-5460, 10.1007/s12346-024-01007-x
    4. Sayed Murad Ali Shah, Yufeng Nie, Abdulwasea Alkhazzan, Cemil Tunç, Anwarud Din, A stochastic hepatitis B model with media coverage and Lévy noise, 2024, 18, 1658-3655, 10.1080/16583655.2024.2414523
    5. Abdulwasea Alkhazzan, Jungang Wang, Yufeng Nie, Hasib Khan, Jehad Alzabut, A stochastic SIRS modeling of transport-related infection with three types of noises, 2023, 76, 11100168, 557, 10.1016/j.aej.2023.06.049
    6. Dandan Yang, Jingfeng Wang, Chuanzhi Bai, Averaging Principle for ψ-Capuo Fractional Stochastic Delay Differential Equations with Poisson Jumps, 2023, 15, 2073-8994, 1346, 10.3390/sym15071346
    7. Padmavathi Ramamoorthi, Senthilkumar Muthukrishnan, Mohanraj Aruchamy, Control of water-borne diseases via awareness and vaccination using multilayer networks, 2023, 12, 26667207, 100282, 10.1016/j.rico.2023.100282
    8. Muhammad Shoaib Arif, Kamaleldin Abodayeh, Yasir Nawaz, Precision in disease dynamics: Finite difference solutions for stochastic epidemics with treatment cure and partial immunity, 2024, 9, 26668181, 100660, 10.1016/j.padiff.2024.100660
    9. Abdulwasea Alkhazzan, Jungang Wang, Yufeng Nie, Hasib Khan, Jehad Alzabut, An effective transport-related SVIR stochastic epidemic model with media coverage and Lévy noise, 2023, 175, 09600779, 113953, 10.1016/j.chaos.2023.113953
    10. Ghaus ur Rahman, J. F. Gómez-Aguilar, Dildar Ahmad, Modeling and analysis of an implicit fractional order differential equation with multiple first-order fractional derivatives and non-local boundary conditions, 2023, 232, 1951-6355, 2367, 10.1140/epjs/s11734-023-00961-y
    11. Amani S. Baazeem, Yasir Nawaz, Muhammad Shoaib Arif, Kamaleldin Abodayeh, Mae Ahmed AlHamrani, Modelling Infectious Disease Dynamics: A Robust Computational Approach for Stochastic SIRS with Partial Immunity and an Incidence Rate, 2023, 11, 2227-7390, 4794, 10.3390/math11234794
    12. Muhammad Shoaib Arif, Kamaleldin Abodayeh, Yasir Nawaz, A Reliable Computational Scheme for Stochastic Reaction–Diffusion Nonlinear Chemical Model, 2023, 12, 2075-1680, 460, 10.3390/axioms12050460
    13. M. Lavanya, B. Sundara Vadivoo, Kottakkaran Sooppy Nisar, Controllability Analysis of Neutral Stochastic Differential Equation Using ψ-Hilfer Fractional Derivative with Rosenblatt Process, 2025, 24, 1575-5460, 10.1007/s12346-024-01178-7
    14. Abdulwasea Alkhazzan, Jungang Wang, Yufeng Nie, Sayed Murad Ali Shah, D.K. Almutairi, Hasib Khan, Jehad Alzabut, Lyapunov-based analysis and worm extinction in wireless networks using stochastic SVEIR model, 2025, 118, 11100168, 337, 10.1016/j.aej.2025.01.040
  • Reader Comments
  • © 2014 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(4994) PDF downloads(860) Cited by(4)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog